aquacobalamin and ethylenediamine

aquacobalamin has been researched along with ethylenediamine* in 1 studies

Other Studies

1 other study(ies) available for aquacobalamin and ethylenediamine

ArticleYear
Exploring novel modified vitamin B12 as a drug carrier: forecast from density functional theory modeling.
    The journal of physical chemistry. B, 2013, Aug-22, Volume: 117, Issue:33

    Three non-native derivatives of vitamin B12 with imidazole, ethylenediamine, and pyrazine as cobalt(III) β-ligands were characterized by applying the BP/def2-TZVP density functional method. The binding of all three ligands is thermodynamically favorable. It is proposed that their synthesis might be possible from aquacobalamin as a starting form of vitamin B12, as has been done in the case of an imidazole derivative of B12 (Hannibal et al. Inorg. Chem. 2007, 46, 3613-3618). Furthermore, the possibility of the formation of their conjugates with cisplatin is investigated. The proposed β-ligands may serve as bridging ligands, binding to the platin ion as N-donors. In parallel, the calculations are done for the previously synthetized B12-cisplatin adduct with CN(-) as a bridging ligand and are compared with available experimental data, allowing assessment of the applied computational protocol. A good agreement between the computed and experimental structural parameters is obtained. In each of the studied structures, the Co-β-ligand bond is weaker than the Pt-β-ligand bond.

    Topics: Cisplatin; Cobalt; Coordination Complexes; Drug Carriers; Ethylenediamines; Imidazoles; Ligands; Models, Theoretical; Pyrazines; Vitamin B 12

2013